MFS
TCRT icon

MSI Financial Services’s Alaunos Therapeutics TCRT Stock Holding History

MSI Financial Services’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Hold
0
– – – 4001
2016
Q3 		– Hold
0
– – – 4017
2016
Q2 		– Sell
-2
Closed -$2.18K – 4089
2016
Q1 		$2K Hold
2
– – ﹤0.01% 3580
2015
Q4 		$2K Buy
+2
New +$3.31K ﹤0.01% 3483
2015
Q3 		– Sell
-3
Closed -$4.95K – 3358
2015
Q2 		$5K Hold
3
– – ﹤0.01% 2461
2015
Q1 		$4K Buy
+3
New +$4.45K ﹤0.01% 2540

Other funds holding TCRT

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

MSI Financial Services's TCRT Position: Q4 2016 in Review

MSI Financial Services held its Alaunos Therapeutics (TCRT) position steady in Q4 2016 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #4001.

MSI Financial Services first reported a position in TCRT in Q1 2015 and has held it in 4 quarters since. The position peaked at $5K in Q2 2015. 136 funds tracked by Wall St. Rank hold TCRT as of Q4 2016.

  • MSI Financial Services held 0 shares of Alaunos Therapeutics worth $0 as of Q4 2016.
  • MSI Financial Services left its Alaunos Therapeutics share count unchanged in Q4 2016.
  • Alaunos Therapeutics made up ﹤0.01% of MSI Financial Services's portfolio in Q4 2016, its #4001 holding.
  • MSI Financial Services first reported a position in Alaunos Therapeutics in Q1 2015 and has held it in 4 quarters since.
  • MSI Financial Services's Alaunos Therapeutics position peaked at $5K in Q2 2015.
  • 136 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q4 2016.

Based on MSI Financial Services's 13F filing for Q4 2016, filed 13 Jan 2017.